申请人:Mederski Werner
公开号:US20050171102A1
公开(公告)日:2005-08-04
Novel compounds of the formula I in which R, R
1
, R
1
, X are as defined in Patent claim
1
, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
公式I中的化合物,其中R、R1、R1、X如专利权要求1所定义,是凝血因子Xa的抑制剂,可用于预防和/或治疗血栓栓塞病和肿瘤的治疗。